David Baltimore

David Baltimore is a Nobel Prize-winning virologist whose discoveries in reverse transcriptase established molecular oncology. He has more recently led pioneering work on using gene editing including CRISPR to engineer CAR-T cells for cancer immunotherapy. His laboratory developed approaches to improve CAR-T cell persistence and function using precise genome editing. He has been an influential voice advocating for responsible CRISPR applications in cancer and other diseases. His career spans foundational virology through modern gene therapy.